未诊断疾病网络(UDN)解决眼部综合征诊断难题
该研究为回顾性介入性病例系列,报告多中心NIH资助的未诊断疾病网络(UDN)在诊断疑难眼部疾病中的协助作用,并展示6例病例。有眼部表型的受试者诊断率为40.2%(452/1123),无眼部表型者为27.8%(276/992);单变量分析中有眼部表型与获得诊断显著相关(OR=1.75;CI=1.45-2.10;P=2.28e-09)。
要点
- UDN中有眼部表型的受试者诊断率为40.2%(452/1123),无眼部表型者为27.8%(276/992)。
- 单变量分析中,有眼部表型与获得诊断显著相关(OR=1.75;CI=1.45-2.10;P=2.28e-09)。
- EPG5和COG4不在遗传性视网膜疾病检测面板中。
核心结论
- UDN是国家资源,可帮助解决包括眼部表型在内的未诊断疾病,促进未诊断疾病研究,并建立合作以改善未诊断疾病患者的治疗选择。
- 包括眼科医生在内的临床医生可与UDN合作,利用基因组技术解决疑难眼部疾病。
研究设计与样本
- 回顾性介入性病例系列。
- 受试者为具有眼部表型、申请并获准加入UDN的参与者,申请时附有眼科医生或其他临床医生根据临床指征撰写的详细支持信,且临床指征的遗传和实验室检测结果未能诊断。
- 使用人类表型本体(Human Phenotype Ontology)编码识别和分类具有眼部表型的受试者。
- 可用的诊断技术包括外显子组、基因组、线粒体和RNA测序、X染色体失活分析、免疫印迹分析等先进基因组技术。
主要发现
- 全国UDN中有眼部表型受试者的诊断率为40.2%(452/1123),无眼部表型受试者的诊断率为27.8%(276/992)。
- 单变量分析中,有眼部表型与获得诊断显著相关(OR=1.75;CI=1.45-2.10;P=2.28e-09)。
- 范德堡UDN站点58例眼部诊断病例/104例总诊断病例中,6例将更详细讨论。
- 范德堡UDN病例包括:TEK/TIE2变异的常染色体显性青光眼;PRPS1新发杂合变异导致小角膜和青光眼并伴有影响女性的X染色体失活偏斜;NADK2纯合变异导致视神经萎缩;EPG5常染色体隐性变异导致视神经萎缩和视锥-视杆营养不良;COG4罕见新发变异导致白内障/视网膜色素变性/眼球震颤表型。
- EPG5和COG4不在遗传性视网膜疾病检测面板中。
关键数值与推荐
- 有眼部表型受试者诊断率:40.2%(452/1123)。
- 无眼部表型受试者诊断率:27.8%(276/992)。
- 有眼部表型与获得诊断的OR=1.75;CI=1.45-2.10;P=2.28e-09。
- 范德堡UDN站点眼部诊断病例58例/总诊断病例104例。
临床怎么用
- 包括眼科医生在内的临床医生可与UDN合作,利用基因组技术解决疑难眼部疾病。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The multicenter NIH-funded Undiagnosed Diseases Network (UDN) exists to diagnose puzzling and newly discovered conditions. We report the UDN's assistance in diagnosing perplexing ocular disorders along with 6 case illustrations. DESIGN: Retrospective Interventional Case Series. SUBJECTS: Participants with ocular phenotypes who had applied and were accepted into the UDN with detailed supporting letters written by ophthalmologists or other clinicians when clinically indicated genetic and laboratory testing results were not diagnostic. METHODS: Human Phenotype Ontology Codes were used to identify and categorize subjects with ocular phenotypes. Advanced genomic technologies (exome, genome, mitochondrial and RNA sequencing, X-inactivation analysis, immunoblot analysis) were available for diagnoses. MAIN OUTCOME MEASURE: Proportion of cases solved by the UDN in subjects manifesting an ophthalmic component of their undiagnosed disorder. RESULTS: The national UDN diagnostic rate for subjects with an eye phenotype was 40.2% (452 of 1123); the diagnostic rate for the other subjects (without an eye) phenotype was 27.8% (276 of 992). In univariate analysis, having an eye phenotype was significantly associated with receiving a diagnosis (odds ratio [OR] = 1.75; CI = 1.45-2.10; P = 2.28e-09). Of 58 eye diagnosed cases/104 total diagnosed cases at the Vanderbilt UDN site, 6 will be discussed more fully. Vanderbilt UDN cases include an autosomal dominant glaucoma with a variant in TEK/TIE2; a de novo heterozygous variant in PRPS1 causing microcornea and glaucoma with skewed X-inactivation affecting a female; a homozygous variant in NADK2 causing optic nerve atrophy; autosomal recessive variants in EPG5 resulting in optic nerve atrophy and cone-rod dystrophy; and a rare de novo variant in COG4 causing a cataract/ retinitis pigmentosa/ nystagmus phenotype. EPG5 and COG4 are not present on inherited retinal disease panels. CONCLUSIONS: The UDN is a national resource available to increase solving undiagnosed diseases including those with ocular phenotypes, facilitate research on undiagnosed diseases, and create a collaboration to improve care options for patients with undiagnosed diseases. Clinicians including ophthalmologists can collaborate with the UDN to solve challenging ocular mysteries using genomic technologies.
引用
- Tinker RJ, Smith LM, Bastarache LA, et al. The Undiagnosed Diseases Network (UDN) Solves Ocular Syndromic Diagnostic Dilemmas. Am J Ophthalmol. 2025. PMID: 40780579. doi:10.1016/j.ajo.2025.07.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。